Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
1.00
Dollar change
-0.06
Percentage change
-5.66
%
Index- P/E- EPS (ttm)- Insider Own45.35% Shs Outstand14.75M Perf Week-2.91%
Market Cap14.78M Forward P/E- EPS next Y- Insider Trans-1.75% Shs Float8.08M Perf Month5.26%
Income- PEG- EPS next Q-0.23 Inst Own0.56% Short Float0.26% Perf Quarter-74.36%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.08 Perf Half Y-84.30%
Book/sh0.55 P/B1.82 EPS next Y- ROA- Short Interest0.02M Perf Year-
Cash/sh0.40 P/C2.52 EPS next 5Y- ROE- 52W Range0.79 - 7.98 Perf YTD-4.76%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-87.47% Beta-
Dividend TTM- Quick Ratio6.99 Sales past 5Y0.00% Gross Margin- 52W Low26.58% ATR (14)0.16
Dividend Ex-Date- Current Ratio6.99 EPS Y/Y TTM- Oper. Margin- RSI (14)45.27 Volatility11.19% 18.18%
Employees- Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-48.08% Payout- Rel Volume0.24 Prev Close1.06
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume249.63K Price1.00
SMA20-6.99% SMA50-8.40% SMA200-67.57% Trades Volume59,028 Change-5.66%
Feb-05-24 08:30AM
Dec-04-23 08:00AM
Nov-29-23 08:00AM
Nov-21-23 10:42AM
10:09AM
08:00AM Loading…
Nov-20-23 08:00AM
Oct-26-23 07:23AM
Sep-18-23 08:30AM
Sep-05-23 08:31AM
Aug-31-23 08:31AM
Aug-29-23 11:39AM
Aug-09-23 09:35AM
Aug-03-23 02:40PM
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McNulty Brian Patrick10% OwnerDec 11Sale1.5546,00571,496660,000Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 08Sale1.6119,05330,633683,002Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 07Sale1.8933,33363,156692,529Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 06Sale2.9527,73381,785709,196Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerDec 04Sale3.9861,331244,097723,062Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 30Sale3.774,84218,273753,728Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 29Sale3.987,39929,445756,149Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 28Sale4.00241964759,849Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 27Sale4.006,42525,715759,969Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 21Sale5.005,00025,000763,181Dec 27 05:33 PM
McNulty Brian Patrick10% OwnerNov 20Sale5.0726,733135,523765,681Dec 27 05:33 PM
Cappy George10% OwnerAug 07Buy7.00119,048833,3362,859,318Aug 24 05:38 PM
Cappy George10% OwnerAug 02Buy7.00157,1701,100,1902,740,270Aug 04 01:42 PM